Profile: Epeius Biotechnologies Corporation is a biopharmaceutical company that focuses on research, development, and delivery of truly effective targeted delivery system that can be injected directly into a vein & delivers genes or molecular therapeutics preferentially to cancerous tumors that have spread throughout the body, without eliciting systemic side effects or organ damage. Our Rexin-G combines Epeius targeted delivery system with a genetically engineered mutant cell-cycle control gene that is lethal to cancer cells in order to eradicate remote primary & metastatic cancers in preclinical studies and to arrest cancer growth, with significant shrinkage & necrosis of solid tumors in humans.